ankylosing spondylitis Archives -

Novartis’ Cosentyx could be heading for a fourth indication after the company published late-stage trial data showing it

Novartis’ Cosentyx heads for fourth indication

https://pharmaphorum.com/news/cosentyx-heads-for/

Swiss pharma hopes to bounce back from Q1 sales disappointment

Amid tough competition, Novartis makes case for rheumatology drug Cosentyx

https://pharmaphorum.com/news/novartis-eric-hughes-cosentyx-secukinumab/

Eli Lilly is hoping new data from its Taltz (ixekizumab) could give it another potentially lucrative indication and

Lilly aims for new indication for Taltz

https://pharmaphorum.com/news/eli-lilly-aims-new-indication-il-17-drug-taltz/

ankylosing spondylitis